We are live on
!
Find out more
Marex Group Portfolio holdings
AUM
$23.6B
Turnover
47.63%
1-Year Est. Return
57.16%
This Fund
S&P 500
This Quarter
Est. Return
+4.95%
1 Year Est. Return
+57.16%
3 Year Est. Return
+254.23%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$15.8B
AUM Growth
-$67.5M
(-0.42%)
Cap. Flow
+$1.48B
Cap. Flow
% of AUM
9.36%
Top 10 Holdings %
Top 10 Hldgs %
30.69%
Holding
1,298
New
335
Increased
347
Reduced
276
Closed
290
Avg Time Held Equity + Options
0.7
years
Top 10 Avg Time Held Equity + Options
0.2
years
Top 20 Avg Time Held Equity + Options
0.5
years
Avg Time Held Equity only
0.7
years
Top 10 Avg Time Held Equity only
0.6
years
Top 20 Avg Time Held Equity only
0.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lumentum
LITE
|
+$471M |
| 2 |
Sandisk
SNDK
|
+$313M |
| 3 |
Goldman Sachs
GS
|
+$179M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$144M |
| 5 |
Eli Lilly
LLY
|
+$113M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$304M |
| 2 |
UnitedHealth
UNH
|
+$174M |
| 3 |
NVIDIA
NVDA
|
+$137M |
| 4 |
Home Depot
HD
|
+$131M |
| 5 |
Netflix
NFLX
|
+$107M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 48.11% |
| 2 | Technology | 25% |
| 3 | Financials | 9.44% |
| 4 | Consumer Discretionary | 4.76% |
| 5 | Healthcare | 4.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
776
Ormat Technologies
ORA
$5.44B
| $299K | ﹤0.01% |
+2,669
| New | +$310K |
2026 Q1
0 quarters
|
|
777
Globant
GLOB
$1.7B
| $297K | ﹤0.01% |
+6,441
| New | +$356K |
2026 Q1
0 quarters
|
|
778
Embraer S.A. ADS
EMBJ
$12.5B
| $297K | ﹤0.01% |
+5,000
| New | +$342K |
2026 Q1
0 quarters
|
|
779
Santander
BSBR
$41.9B
| $297K | ﹤0.01% |
+50,000
| New | +$318K |
2026 Q1
0 quarters
|
|
780
EOG Resources
EOG
$80B
| $296K | ﹤0.01% |
+2,048
| New | +$249K |
2026 Q1
0 quarters
|
|
781
Factset
FDS
$10.6B
| $296K | ﹤0.01% |
1,363
+408
| +43% | +$95.2K |
2025 Q4
1 quarter
|
|
782
Cognizant
CTSH
$29.3B
| $296K | ﹤0.01% |
+4,817
| New | +$345K |
2026 Q1
0 quarters
|
|
783
eBay
EBAY
$53.3B
| $295K | ﹤0.01% |
+3,242
| New | +$291K |
2026 Q1
0 quarters
|
|
784
FIVE9
FIVN
$2.49B
| $294K | ﹤0.01% |
+19,361
| New | +$337K |
2026 Q1
0 quarters
|
|
785
Neuberger High Yield Strategies Fund Inc
NHS
$221M
| $292K | ﹤0.01% |
+45,000
| New | +$330K |
2026 Q1
0 quarters
|
|
786
First Trust NASDAQ Cybersecurity ETF
CIBR
$17.6B
| $291K | ﹤0.01% |
+4,649
| New | +$312K |
2026 Q1
0 quarters
|
|
787
Howmet Aerospace
HWM
$84.8B
| $289K | ﹤0.01% |
+1,255
| New | +$292K |
2026 Q1
0 quarters
|
|
788
MacroGenics
MGNX
$217M
| $289K | ﹤0.01% |
+100,000
| New | +$213K |
2026 Q1
0 quarters
|
|
789
Novavax
NVAX
$2.08B
| $289K | ﹤0.01% |
35,494
| – | – |
2022 Q4
13 quarters
|
|
790
Autodesk
ADSK
$50.6B
| $288K | ﹤0.01% |
1,205
-213
| -15% | -$53.5K |
2025 Q4
1 quarter
|
|
791
Protara Therapeutics
TARA
$148M
| $288K | ﹤0.01% |
55,250
-30,000
| -35% | -$178K |
2025 Q3
2 quarters
|
|
792
Atlassian
TEAM
$51.3B
| $288K | ﹤0.01% |
4,217
+2,172
| +106% | +$214K |
2025 Q1
4 quarters
|
|
793
Molson Coors Class B
TAP
$7.41B
| $287K | ﹤0.01% |
+6,662
| New | +$316K |
2026 Q1
0 quarters
|
|
794
Rhythm Pharmaceuticals
RYTM
$6.17B
| $286K | ﹤0.01% |
+3,288
| New | +$320K |
2026 Q1
0 quarters
|
|
795
Baozun
BZUN
$202M
| $285K | ﹤0.01% |
119,224
-11,550
| -9% | -$30K |
2022 Q4
13 quarters
|
|
796
Twenty One Capital Inc
XXI
$1.98B
| $284K | ﹤0.01% |
44,400
+15,600
| +54% | +$114K |
2025 Q4
1 quarter
|
|
|
797
PUT
Twenty One Capital Inc
XXI
$1.98B
| $284K | ﹤0.01% |
44,400
+15,600
| +54% | +$114K |
2025 Q4
1 quarter
|
|
798
UiPath
PATH
$6.87B
| $284K | ﹤0.01% |
25,556
-26,381
| -51% | -$336K |
2023 Q4
9 quarters
|
|
799
Eldorado Gold
EGO
$9.03B
| $284K | ﹤0.01% |
8,262
+2,610
| +46% | +$106K |
2025 Q3
2 quarters
|
|
800
Wendy's
WEN
$1.26B
| $282K | ﹤0.01% |
40,560
+25,716
| +173% | +$198K |
2025 Q4
1 quarter
|
|
Similar funds
Marex Group's Q1 2026 Portfolio in Review
As of Q1 2026, Marex Group held 1,298 positions worth $15.8B, down 0.42% from $15.9B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Marex Group deployed $1.48B of net new capital in Q1 2026, opening 335 new positions and adding to 347 existing holdings. Its largest new stake was Lumentum: 857,171 shares worth $602M.
By sector, the portfolio is most concentrated in Miscellaneous at 48% of assets, down from 51% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $304M trimmed.
- Marex Group's largest Q1 2026 buy was Lumentum: 857,171 shares worth $602M.
- Marex Group added most to Goldman Sachs in Q1 2026, an estimated $179M increase.
- Marex Group's biggest Q1 2026 reduction was Meta Platforms (Facebook), cutting an estimated $304M.
- Marex Group fully exited Dycom Industries in Q1 2026, selling an estimated $13.3M.
- Marex Group's ten largest holdings make up 31% of its $15.8B portfolio in Q1 2026.
- Marex Group opened 335 new positions and closed 290 in Q1 2026.
- Marex Group's portfolio value fell 0.42% quarter-over-quarter to $15.8B.
Based on Marex Group's 13F filing for Q1 2026, filed 13 May 2026.